These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 38182406)

  • 21. Interleukin-1 Links Autoimmune and Autoinflammatory Pathophysiology in Mixed-Pattern Psoriasis.
    Kölliker Frers R; Otero-Losada M; Kobiec T; Herrera MI; Udovin L; Kusnier CF; Capani F
    Mediators Inflamm; 2021; 2021():2503378. PubMed ID: 34697538
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeted Treatment of Diseases of Immune Dysregulation.
    Mohan S
    Rheum Dis Clin North Am; 2023 Nov; 49(4):913-929. PubMed ID: 37821203
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mesenchymal Stem Cells in the Pathogenesis and Therapy of Autoimmune and Autoinflammatory Diseases.
    Zaripova LN; Midgley A; Christmas SE; Beresford MW; Pain C; Baildam EM; Oldershaw RA
    Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003230
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The classification, genetic diagnosis and modelling of monogenic autoinflammatory disorders.
    Moghaddas F; Masters SL
    Clin Sci (Lond); 2018 Sep; 132(17):1901-1924. PubMed ID: 30185613
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modulation of Autoimmune and Autoinflammatory Diseases by Gasdermins.
    Liang F; Qin W; Zeng Y; Wang D
    Front Immunol; 2022; 13():841729. PubMed ID: 35720396
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Autoimmunity and autoinflammation: A systems view on signaling pathway dysregulation profiles.
    Arakelyan A; Nersisyan L; Poghosyan D; Khondkaryan L; Hakobyan A; Löffler-Wirth H; Melanitou E; Binder H
    PLoS One; 2017; 12(11):e0187572. PubMed ID: 29099860
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanistic immunological based classification of rheumatoid arthritis.
    McGonagle D; Watad A; Savic S
    Autoimmun Rev; 2018 Nov; 17(11):1115-1123. PubMed ID: 30213700
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A flowcytometric analysis to efficiently quantify multiple innate immune cells and T Cell subsets in human blood.
    Draxler DF; Madondo MT; Hanafi G; Plebanski M; Medcalf RL
    Cytometry A; 2017 Apr; 91(4):336-350. PubMed ID: 28264143
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular mechanisms in genetically defined autoinflammatory diseases: disorders of amplified danger signaling.
    de Jesus AA; Canna SW; Liu Y; Goldbach-Mansky R
    Annu Rev Immunol; 2015; 33():823-74. PubMed ID: 25706096
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autoinflammatory diseases: update on classification diagnosis and management.
    Pathak S; McDermott MF; Savic S
    J Clin Pathol; 2017 Jan; 70(1):1-8. PubMed ID: 27646526
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Systemic autoinflammatory diseases.
    Krainer J; Siebenhandl S; Weinhäusel A
    J Autoimmun; 2020 May; 109():102421. PubMed ID: 32019685
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Autoinflammatory diseases].
    Mosdósi B; Tóth B
    Orv Hetil; 2018 Jun; 159(23):898-907. PubMed ID: 29860887
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Autoinflammatory syndromes].
    Antón J
    Med Clin (Barc); 2011 Jan; 136 Suppl 1():3-9. PubMed ID: 21596180
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low percentages of regulatory T cells in common variable immunodeficiency (CVID) patients with autoimmune diseases and its association with increased numbers of CD4+CD45RO+ T and CD21
    López-Herrera G; Segura-Méndez NH; O'Farril-Romanillos P; Nuñez-Nuñez ME; Zarate-Hernández MC; Mogica-Martínez D; Yamazaki-Nakashimada MA; Staines-Boone AT; Santos-Argumedo L; Berrón-Ruiz L
    Allergol Immunopathol (Madr); 2019; 47(5):457-466. PubMed ID: 31103252
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Broadening the definition of autoinflammation.
    Masters SL
    Semin Immunopathol; 2015 Jul; 37(4):311-2. PubMed ID: 25994947
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Systemic Autoinflammatory Diseases: A Growing Family of Disorders of Overlapping Immune Dysfunction.
    Gutierrez MJ; Lapidus SK
    Rheum Dis Clin North Am; 2022 Feb; 48(1):371-395. PubMed ID: 34798958
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The monogenic autoinflammatory diseases define new pathways in human innate immunity and inflammation.
    Manthiram K; Zhou Q; Aksentijevich I; Kastner DL
    Nat Immunol; 2017 Jul; 18(8):832-842. PubMed ID: 28722725
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Innate immunity, autoimmunity and autoinflammation].
    Bendtzen K
    Ugeskr Laeger; 2011 Sep; 173(38):2337-40. PubMed ID: 21936976
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adaptive and Innate Immunity in Psoriasis and Other Inflammatory Disorders.
    Schön MP
    Front Immunol; 2019; 10():1764. PubMed ID: 31402919
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Innately versatile: γδ17 T cells in inflammatory and autoimmune diseases.
    Papotto PH; Reinhardt A; Prinz I; Silva-Santos B
    J Autoimmun; 2018 Feb; 87():26-37. PubMed ID: 29203226
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.